InvestSMART

Anatara Lifesciences Ltd (ASX:ANR)

ALERT: Price-sensitive ASX Announcement for ANR
Current share price for ANR : $0.009 0 (0%)+
Announcement
Release
18 Aug 2026 6:18PM
Price at Release
$0.009
Full Release
download
Summary
Anatara Lifesciences Ltd, an Australian company, reported its financial performance for the year ending 30 June 2026. The company experienced a net loss of $933,230, a 52% decrease from the previous year's loss. The loss per share was 0.34 cents compared to 0.95 cents in 2025. The report highlighted no dividends were declared, continuing the trend of no dividends in previous years. In terms of financial position, the company had total assets of $820,395 and liabilities totaling $108,857, resulting in net assets of $711,538. The company undertook various transactions including the issuance of new shares, which raised $1.2 million, offset by capital raising costs of $123,200. The financial statements were audited and an unqualified opinion was given, with an emphasis on the going concern of the company. The financial risk management section addressed market risks, particularly foreign exchange and interest rate risks, indicating minimal exposure due to the operations being mainly in Australian dollars.
Key Points
  • Net loss of $933,230 for the year, a 52% decrease from 2025.
  • Loss per share was 0.34 cents for 2026.
  • No dividends were declared for the year.
  • Total assets stood at $820,395 with liabilities of $108,857.
  • Net assets amounted to $711,538.
  • Raised $1.2 million through share issuance, with $123,200 in costs.
  • Audited with an unqualified opinion and emphasis on going concern.
  • Minimal foreign exchange and interest rate exposure as operations are primarily in Australian dollars.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.